Standard
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. / Al Nakouzi, Nader; Le Moulec, Sylvestre; Albigès, Laurence; Wang, Chris Kedong; Beuzeboc, Philippe; Gross-Groupil, Marine; de La Motte Rouge, Thibault; Guillot, Aline; Gajda, Dorota; Massard, Christophe; Gleave, Martin; Fizazi, Karim; Loriot, Yohann.
In:
European Urology, 08.2015.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Al Nakouzi, N, Le Moulec, S, Albigès, L, Wang, CK, Beuzeboc, P, Gross-Groupil, M, de La Motte Rouge, T, Guillot, A, Gajda, D, Massard, C, Gleave, M, Fizazi, K & Loriot, Y 2015, 'Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies', European Urology.
APA
Al Nakouzi, N., Le Moulec, S., Albigès, L., Wang, C. K., Beuzeboc, P., Gross-Groupil, M., de La Motte Rouge, T., Guillot, A., Gajda, D., Massard, C., Gleave, M., Fizazi, K., & Loriot, Y. (2015). Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. European Urology.
Vancouver
Al Nakouzi N, Le Moulec S, Albigès L, Wang CK, Beuzeboc P, Gross-Groupil M et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. European Urology. 2015 Aug.
Author
Al Nakouzi, Nader ; Le Moulec, Sylvestre ; Albigès, Laurence ; Wang, Chris Kedong ; Beuzeboc, Philippe ; Gross-Groupil, Marine ; de La Motte Rouge, Thibault ; Guillot, Aline ; Gajda, Dorota ; Massard, Christophe ; Gleave, Martin ; Fizazi, Karim ; Loriot, Yohann. / Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. In: European Urology. 2015.
Bibtex
@article{59ab5c595fa74239ab31fdfddad70c9b,
title = "Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies",
author = "{Al Nakouzi}, Nader and {Le Moulec}, Sylvestre and Laurence Albig{\`e}s and Wang, {Chris Kedong} and Philippe Beuzeboc and Marine Gross-Groupil and {de La Motte Rouge}, Thibault and Aline Guillot and Dorota Gajda and Christophe Massard and Martin Gleave and Karim Fizazi and Yohann Loriot",
year = "2015",
month = aug,
language = "English",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
}
RIS
TY - JOUR
T1 - Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies
AU - Al Nakouzi, Nader
AU - Le Moulec, Sylvestre
AU - Albigès, Laurence
AU - Wang, Chris Kedong
AU - Beuzeboc, Philippe
AU - Gross-Groupil, Marine
AU - de La Motte Rouge, Thibault
AU - Guillot, Aline
AU - Gajda, Dorota
AU - Massard, Christophe
AU - Gleave, Martin
AU - Fizazi, Karim
AU - Loriot, Yohann
PY - 2015/8
Y1 - 2015/8
M3 - Journal article
JO - European Urology
JF - European Urology
SN - 0302-2838
ER -
